Supplemental Information

 
1. Pitch Decks
          Pitch Deck - View
          Extended Pitch deck -

2. Sepsis Diagnosis Market
          Market Characteristics -
          The average financial loss for a U.S. hospital from sepsis is $34 million annually, - View
          2014 UK Gov report projecting antimicrobial bacteria infection deaths exceeding cancer by 2050 - View

3. Product Development
          Product Data Sheet - View
          Product Development Plan - View
          Predecessor NASA spin-off (Early Warning Inc.) Website and Product Video - Link

4. Data
          Publication: Carbapenem-Resistant Enterobacteriaceae Testing in 45 Minutes Using Oligonucleotide Detection Tags - View
          Publication: Highly Sensitive Bacteria Quantification Using Immunomagnetic Separation and Electrochemical Detection
               of Guanine-Labeled Secondary Beads - View

5. Intellectual Property
          Patent Overview - View
          US 11,105,801:  Bioanalyte signal amplification and detection with artificial intelligence diagnosis -  View   Canada   Europe (Pending)
          US 11,175,285: Ultra-sensitive bioanalyte quantification from self-assembled quadruplex tags - View   Canada
          US 9.624,532: Ultra-sensitive detection of extremely low level biological analytes - View   Canada  France  Germany  Great Britain

6. Sales & Marketing
          Marketing Plan -

7. Competition
         Competitive Position -
         Luminex    Sepsis Page     DiaSorin 2021 Acquisition for $1.8 B
         GenMark    Sepsis Page    Roche 2021 Acquisition for $1.8 B
         BioFire       Sepsis Page     bioMérieux 2014 Acquisition for $486 M

8. Team
          Team Bios - View

9  Financial
          Funding Strategy and Cap Table - View
          Guanine, Inc - Financials and Incorporation Documents - View
          Guanine Dx, Inc - Proforma - View
          Guanine Dx Inc. - Headcount and Budget - View
          NewChip Agreement - View
          Comparable Company Valuations -